ORPHENADRINE CITRATE

Generic: ORPHENADRINE CITRATE

Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
ORPHENADRINE CITRATEActive Substance
2003-03-04Original Approval

ORPHENADRINE CITRATE is FDA application ANDA040463, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
PAIN
67 reports
2
NAUSEA
54 reports
3
FATIGUE
49 reports
4
ANXIETY
46 reports
5
DRUG INEFFECTIVE
45 reports
6
ARTHRALGIA
41 reports
7
HEADACHE
40 reports
8
DIARRHOEA
38 reports
9
DIZZINESS
38 reports
10
VOMITING
32 reports